AVITA Medical, Inc. financial data

Symbol
RCEL on Nasdaq, AVHHL on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
28159 Avenue Stanford, Suite 220, Valencia, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Avita Therapeutics, Inc. (to 12/10/2020), Avita Medical, Ltd. (to 6/30/2020)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 665 % -10.9%
Quick Ratio 47.1 % +115%
Debt-to-equity 123 % +607%
Return On Equity -118 % -209%
Return On Assets -52.8 % -62.8%
Operating Margin -101 % -25.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26M shares +2.01%
Common Stock, Shares, Outstanding 25.9M shares +1.97%
Entity Public Float 432M USD +268%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 25.8M shares +2.06%
Weighted Average Number of Shares Outstanding, Diluted 25.8M shares +2.06%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 54.1M USD +32.5%
Cost of Revenue 7.53M USD +11.6%
Research and Development Expense 21.2M USD +26.1%
Selling and Marketing Expense 49.7M USD +75.6%
General and Administrative Expense 30.4M USD +22.5%
Operating Income (Loss) -54.4M USD -66.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -49.7M USD -63.2%
Income Tax Expense (Benefit) 86K USD +21.1%
Net Income (Loss) Attributable to Parent -49.8M USD -63.1%
Earnings Per Share, Basic 0.85 USD/shares -46.3%
Earnings Per Share, Diluted 0.85 USD/shares -46.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 17.5M USD -53.4%
Marketable Securities, Current 36.6M USD +28.2%
Accounts Receivable, after Allowance for Credit Loss, Current 8.72M USD +51.5%
Inventory, Net 6.71M USD +119%
Other Assets, Current 8K USD -98.5%
Assets, Current 73M USD -5.86%
Property, Plant and Equipment, Net 7.02M USD +340%
Operating Lease, Right-of-Use Asset 3.94M USD +139%
Intangible Assets, Net (Excluding Goodwill) 545K USD +19.5%
Other Assets, Noncurrent 473K USD +66%
Assets 87.8M USD +1.73%
Liabilities, Current 13.8M USD -0.17%
Contract with Customer, Liability, Noncurrent 340K USD -9.09%
Operating Lease, Liability, Noncurrent 3.28M USD +213%
Other Liabilities, Noncurrent 715K USD +42.1%
Liabilities 63.5M USD +286%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.56M USD -120%
Retained Earnings (Accumulated Deficit) -332M USD -17.7%
Stockholders' Equity Attributable to Parent 23.9M USD -65.2%
Liabilities and Equity 87.8M USD +1.73%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.9M USD -130%
Net Cash Provided by (Used in) Financing Activities 631K USD +269%
Net Cash Provided by (Used in) Investing Activities 15.1M USD -19.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 25.9M shares +1.97%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.17M USD -152%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 17.5M USD -53.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.36K USD
Deferred Tax Assets, Valuation Allowance 63.3M USD +12%
Deferred Tax Assets, Gross 63.9M USD +12.7%
Operating Lease, Liability 4.1M USD +141%
Depreciation 707K USD +37.3%
Payments to Acquire Property, Plant, and Equipment 1.15M USD +304%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -59.3M USD -97%
Lessee, Operating Lease, Liability, to be Paid 5.17M USD +172%
Operating Lease, Liability, Current 820K USD +25%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.13M USD +155%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.17M USD +57.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +25.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.07M USD +433%
Lessee, Operating Lease, Liability, to be Paid, Year Three 773K USD +105%
Deferred Tax Assets, Operating Loss Carryforwards 50.4M USD +4.18%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 658K USD
Operating Lease, Payments 991K USD +21.4%
Additional Paid in Capital 359M USD +4.29%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 52K USD +57.6%
Depreciation, Depletion and Amortization 203K USD +50.4%
Deferred Tax Assets, Net of Valuation Allowance 624K USD +160%
Share-based Payment Arrangement, Expense 11.2M USD +74.3%
Interest Expense 3.84M USD +19143%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%